Cannell & Co. Moderna, Inc. Call Options Transaction History
Cannell & Co.
- $3.01 Billion
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
1,054Shares Held
242MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.38 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.16 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.4 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$822 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$395 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $21.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...